Webb27 maj 2024 · The impact score (IS) 2024 of Therapeutic Advances in Cardiovascular Disease is 3.03, which is computed in 2024 as per its definition. Therapeutic Advances in … WebbTher Adv Respir Dis 2024, Vol. 13: 1–28 DOI: 10.1177/ 1753466619884532 ... Asthma and chronic obstructive pulmonary dis-ease (COPD) are serious public health concerns …
Archive of "Therapeutic Advances in Respiratory Disease".
WebbThe prevalence of comorbidities in the GOLDEN 3 and 4 RCTs, as well as their impact on the efficacy and safety of GLY, were not assessed in the original analysis. 17 A secondary analysis of GLY in participants with pre-existing cardiovascular (CV) risk factors showed that GLY had an acceptable safety profile and improved lung function and … Webb20 dec. 2024 · The use of multiple respiratory inhalers requiring different inhalation techniques has been shown to have an adverse effect on clinical outcomes in patients with COPD 23 and asthma. 24 Patients who believe using their inhaler is an important part of their asthma management demonstrate higher levels of correct inhaler use. 21 However, … imperial gynaecology advice
Incidence and Prognostic Factors of Respiratory Viral Infections in ...
WebbSince the introduction of CPFE as a clinical syndrome by Cottin et al in 2005, there has been an ongoing evaluation of the impact of emphysema in the natural history of pulmonary fibrosis. 7, 8 The need for future studies to determine the etiology, morbidity, mortality and novel therapeutics for CPFE either with or without PH, has been … WebbAdvanced Search User Guide Journal List; Ther Adv Infect Dis; Journal List; Ther Adv Infect Dis; Therapeutic Advances in Infectious Disease Vols. 1 to 10; 2013 to 2024; Vol. 10 … WebbAdvances in Therapy Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 0741-238X. Journal ... Enter journal title, issn or abbr in this box to search. … imperial guest house plymouth